Spots Global Cancer Trial Database for stage iib breast cancer

Every month we try and update this database with for stage iib breast cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Aerobic and Strength Training Exercise in Improving Fitness and Arm Health During and After Radiation Therapy in Patients With Stage II-III Breast Cancer	NCT03102866	Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea...	Best Practice Exercise Interv... Quality-of-Life... Questionnaire A...	-	Ohio State University Comprehensive Cancer Center
Cardiac Rehabilitation Program in Improving Cardiorespiratory Fitness in Stage 0-III Breast Cancer Survivors	NCT03039140	Cancer Survivor Stage 0 Breast ... Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea...	Educational Int... Exercise Interv... Quality-of-Life... Questionnaire A...	30 Years - 75 Years	Ohio State University Comprehensive Cancer Center
Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast Surgery	NCT03188393	Invasive Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea...	Biopsy of Breas...	18 Years -	NRG Oncology
Cyclophosphamide and Paclitaxel With or Without Trastuzumab in Stage I-II Breast Cancer Who Have Undergone Surgery	NCT01106898	Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIB Breas...	cyclophosphamid... paclitaxel trastuzumab laboratory biom...	20 Years -	University of Nebraska
Biomarkers in Tissue Samples From Patients With Newly Diagnosed Breast Cancer Treated With Zoledronic Acid	NCT01409811	Estrogen Recept... Invasive Ductal... Progesterone Re... Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIB Breas...	zoledronic acid laboratory biom... therapeutic con...	-	City of Hope Medical Center
Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast Surgery	NCT03188393	Invasive Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea...	Biopsy of Breas...	18 Years -	NRG Oncology
Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer	NCT03345420	Ductal Breast C... Invasive Breast... Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas...	Hypofractionate...	18 Years -	University of Utah
Mindfulness Meditation or Survivorship Education in Improving Behavioral Symptoms in Younger Stage 0-III Breast Cancer Survivors (Pathways to Wellness)	NCT03025139	Cancer Survivor Early-Stage Bre... Stage 0 Breast ... Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea...	Educational Int... Laboratory Biom... Meditation Ther... Questionnaire A...	- 49 Years	Jonsson Comprehensive Cancer Center
Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients With Breast Cancer	NCT02400060	Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage 0 Breast ...	Telephone-Based... Survey Administ... Laboratory Biom...	18 Years -	Ohio State University Comprehensive Cancer Center
Survivorship Care Plan in Promoting Physical Activity in Breast or Colorectal Cancer Survivors in Wisconsin	NCT02677389	Cancer Survivor Healthy Subject Stage I Colorec... Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIA Color... Stage IIB Breas... Stage IIB Color... Stage IIC Color... Stage IIIA Brea... Stage IIIA Colo... Stage IIIB Brea... Stage IIIB Colo... Stage IIIC Brea... Stage IIIC Colo...	Educational Int... Internet-Based ... Monitoring Devi... Quality-of-Life... Questionnaire A...	30 Years - 75 Years	University of Wisconsin, Madison
Phase II Study of Fluorine-18 3'-Deoxy-3'-Fluorothymidine (F-18-FLT) in Invasive Breast Cancer	NCT00572728	Stage IIB Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea...	CT 18F-FLT PET	18 Years -	National Cancer Institute (NCI)
Exercise Intervention in Preventing Breast Cancer Recurrence in Postmenopausal Breast Cancer Survivors	NCT02235051	Cancer Survivor Estrogen Recept... Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea... Postmenopausal	exercise interv... laboratory biom... questionnaire a... quality-of-life...	56 Years -	City of Hope Medical Center
Pazopanib in Treating Patients With Newly Diagnosed or Locally and/or Regionally Recurrent Breast Cancer That Can Be Removed By Surgery	NCT00450879	Male Breast Car... Recurrent Breas... Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea...	Pazopanib Hydro... Dynamic Contras... Pharmacological... Laboratory Biom...	18 Years -	National Cancer Institute (NCI)
Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer Survivors	NCT03284346	Cancer Survivor No Evidence of ... Obesity Overweight Prostate Carcin... Sedentary Lifes... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea...	Exercise Interv... Exercise Interv... Laboratory Biom... Monitoring Devi... Quality-of-Life... Questionnaire A...	18 Years -	University of Southern California
Chemotherapy Before Surgery and Tissue Sample Collection in Patients With Stage IIA-IIIC Breast Cancer	NCT01897441	Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast...	Cyclophosphamid... Cytology Specim... Doxorubicin Hyd... Laboratory Biom... Paclitaxel Trastuzumab	18 Years -	Albert Einstein College of Medicine
Mindfulness Meditation or Survivorship Education in Improving Behavioral Symptoms in Younger Stage 0-III Breast Cancer Survivors (Pathways to Wellness)	NCT03025139	Cancer Survivor Early-Stage Bre... Stage 0 Breast ... Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea...	Educational Int... Laboratory Biom... Meditation Ther... Questionnaire A...	- 49 Years	Jonsson Comprehensive Cancer Center
MRI and Cardio-Pulmonary Exercise Testing in Evaluating Exercise Intolerance in Patients With Stage I-III Breast Cancer After Chemotherapy Treatment	NCT02702830	Healthy Subject Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea...	Cardiopulmonary... Magnetic Resona...	40 Years - 65 Years	Wake Forest University Health Sciences
Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer	NCT03345420	Ductal Breast C... Invasive Breast... Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas...	Hypofractionate...	18 Years -	University of Utah
High-Intensity Interval Training for Stage I-III Breast Cancer Patients	NCT02454777	Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea...	Exercise Interv... Laboratory Biom... Quality-of-Life... Questionnaire A...	18 Years -	University of Southern California
Ultrasound in Detecting Taxane-Induced Neuropathy in Patients With Breast Cancer	NCT03139435	Peripheral Neur... Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast...	Biopsy Questionnaire A... Ultrasound Tomo...	-	Wake Forest University Health Sciences
Intraoperative Electron Beam Radiotherapy Boost in Treating Patients With Stage I-II Breast Cancer Undergoing Surgery With Reconstruction	NCT02927912	Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIB Breas...	Electron Beam T... Lumpectomy Quality-of-Life... Questionnaire A... Radiation Thera... Reconstructive ...	18 Years -	Ohio State University Comprehensive Cancer Center
Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer	NCT04553770	Early-stage Bre... Hormone Recepto... Invasive Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage III Breas...	Anastrozole Therapeutic Con... Trastuzumab Der...	18 Years -	Jonsson Comprehensive Cancer Center
Survivorship Care Plan in Promoting Physical Activity in Breast or Colorectal Cancer Survivors in Wisconsin	NCT02677389	Cancer Survivor Healthy Subject Stage I Colorec... Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIA Color... Stage IIB Breas... Stage IIB Color... Stage IIC Color... Stage IIIA Brea... Stage IIIA Colo... Stage IIIB Brea... Stage IIIB Colo... Stage IIIC Brea... Stage IIIC Colo...	Educational Int... Internet-Based ... Monitoring Devi... Quality-of-Life... Questionnaire A...	30 Years - 75 Years	University of Wisconsin, Madison
Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)	NCT01077154	Breast Cancer	Placebo Denosumab	18 Years -	Amgen
Broccoli Sprout Extract in Treating Patients With Breast Cancer	NCT01753908	Ductal Breast C... Ductal Breast C... Estrogen Recept... Estrogen Recept... Invasive Breast... Lobular Breast ... Postmenopausal Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIB Breas...	Broccoli Sprout... Laboratory Biom... Pharmacological... Placebo	21 Years -	Roswell Park Cancer Institute
A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients With Locally Advanced Breast Cancer	NCT00378313	Stage IIB Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IV Breast... Breast Cancer Locally Advance...	gemcitabine, ep...	18 Years -	NSABP Foundation Inc
Pazopanib in Treating Patients With Newly Diagnosed or Locally and/or Regionally Recurrent Breast Cancer That Can Be Removed By Surgery	NCT00450879	Male Breast Car... Recurrent Breas... Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea...	Pazopanib Hydro... Dynamic Contras... Pharmacological... Laboratory Biom...	18 Years -	National Cancer Institute (NCI)
Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast Cancer	NCT02315196	Estrogen Recept... HER2-negative B... Progesterone Re... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Triple-negative...	pegylated lipos... epirubicin hydr... carboplatin therapeutic con... paclitaxel laboratory biom... quality-of-life...	18 Years -	Rutgers, The State University of New Jersey
Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast Cancer	NCT02315196	Estrogen Recept... HER2-negative B... Progesterone Re... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Triple-negative...	pegylated lipos... epirubicin hydr... carboplatin therapeutic con... paclitaxel laboratory biom... quality-of-life...	18 Years -	Rutgers, The State University of New Jersey
Vaccine Therapy and Cyclophosphamide in Treating Patients With Stage II-III Breast or Stage II-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer	NCT01606241	Recurrent Breas... Recurrent Fallo... Recurrent Ovari... Recurrent Prima... Stage IIA Breas... Stage IIA Fallo... Stage IIA Ovari... Stage IIB Breas... Stage IIB Fallo... Stage IIB Ovari... Stage IIC Fallo... Stage IIC Ovari... Stage IIIA Brea... Stage IIIA Fall... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIB Brea... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIC Brea... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Prim... Stage IV Fallop... Stage IV Ovaria... Stage IV Primar...	Cyclophosphamid... Laboratory Biom... Multi-epitope F...	18 Years -	Mayo Clinic
A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients With Locally Advanced Breast Cancer	NCT00378313	Stage IIB Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IV Breast... Breast Cancer Locally Advance...	gemcitabine, ep...	18 Years -	NSABP Foundation Inc
Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer	NCT04553770	Early-stage Bre... Hormone Recepto... Invasive Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage III Breas...	Anastrozole Therapeutic Con... Trastuzumab Der...	18 Years -	Jonsson Comprehensive Cancer Center
Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)	NCT05512364	ER-positive Bre... HER2-negative B... Stage IIB Breas... Stage III Breas...	Elacestrant Tamoxifen Letrozole 2.5mg Anastrozole 1mg Exemestane 25 M...	18 Years -	European Organisation for Research and Treatment of Cancer - EORTC
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)	NCT02728596	Febrile Neutrop... Stage 0 Breast ... Stage 0 Colorec... Stage 0 Non-Sma... Stage I Colorec... Stage IA Breast... Stage IA Non-Sm... Stage IB Breast... Stage IB Non-Sm... Stage IIA Breas... Stage IIA Color... Stage IIA Non-S... Stage IIB Breas... Stage IIB Color... Stage IIB Non-S... Stage IIC Color... Stage IIIA Brea... Stage IIIA Colo... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Colo... Stage IIIB Non-... Stage IIIC Brea... Stage IIIC Colo... Stage IV Breast... Stage IV Non-Sm... Stage IVA Color... Stage IVB Color...	Preventive Inte... Quality-of-Life... Questionnaire A...	18 Years -	SWOG Cancer Research Network
Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer	NCT04553770	Early-stage Bre... Hormone Recepto... Invasive Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage III Breas...	Anastrozole Therapeutic Con... Trastuzumab Der...	18 Years -	Jonsson Comprehensive Cancer Center
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer	NCT03414970	Ductal Breast C... Invasive Breast... Lobular Breast ... Medullary Breas... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea... Tubular Breast ...	Radiation Thera... Questionnaire A... Quality-of-Life... Laboratory Biom... Hypofractionate...	18 Years -	Alliance for Clinical Trials in Oncology
eHealth Weight Loss Program in African American Breast Cancer Survivors	NCT02699983	Cancer Survivor Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage 0 Breast ...	Behavioral Diet... Exercise Interv... Activity Monito...	21 Years - 75 Years	Rutgers, The State University of New Jersey
Phase II Study of Fluorine-18 3'-Deoxy-3'-Fluorothymidine (F-18-FLT) in Invasive Breast Cancer	NCT00572728	Stage IIB Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea...	CT 18F-FLT PET	18 Years -	National Cancer Institute (NCI)
Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)	NCT01077154	Breast Cancer	Placebo Denosumab	18 Years -	Amgen
Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)	NCT05512364	ER-positive Bre... HER2-negative B... Stage IIB Breas... Stage III Breas...	Elacestrant Tamoxifen Letrozole 2.5mg Anastrozole 1mg Exemestane 25 M...	18 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Web-Based Decision Aid in Improving Informed Decisions in Patients With Stage 0-IIIA Breast Cancer Considering Contralateral Prophylactic Mastectomy	NCT03061175	Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea...	Internet-Based ... Survey Administ...	18 Years -	Rutgers, The State University of New Jersey
Effects of Chemotherapy on Intestinal Bacteria in Patients With Newly Diagnosed Breast Cancer	NCT02370277	Ductal Breast C... Invasive Breast... Stage I Breast ... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea...	Cytology Specim... Laboratory Biom... Questionnaire A...	18 Years -	University of Southern California
Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors	NCT01849250	Benign Breast N... Ductal Breast C... Invasive Breast... Lobular Breast ... Paget Disease o... Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea...	Docosahexaenoic... Placebo	18 Years -	National Cancer Institute (NCI)
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)	NCT02728596	Febrile Neutrop... Stage 0 Breast ... Stage 0 Colorec... Stage 0 Non-Sma... Stage I Colorec... Stage IA Breast... Stage IA Non-Sm... Stage IB Breast... Stage IB Non-Sm... Stage IIA Breas... Stage IIA Color... Stage IIA Non-S... Stage IIB Breas... Stage IIB Color... Stage IIB Non-S... Stage IIC Color... Stage IIIA Brea... Stage IIIA Colo... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Colo... Stage IIIB Non-... Stage IIIC Brea... Stage IIIC Colo... Stage IV Breast... Stage IV Non-Sm... Stage IVA Color... Stage IVB Color...	Preventive Inte... Quality-of-Life... Questionnaire A...	18 Years -	SWOG Cancer Research Network
Comparative Study of Neoadjuvant Chemotherapy With and Without Zometa for Management of Locally Advanced Breast Cancers	NCT01367288	Locally Advance... Ductal Histolog... Without Her 2 O...	Zometa + Neoadj... Neoadjuvant the...	18 Years -	Hospices Civils de Lyon
Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancer	NCT01730833	HER2-positive B... Recurrent Breas... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... Breast Adenocar... Inflammatory Br...	pertuzumab trastuzumab paclitaxel albu... laboratory biom...	19 Years -	City of Hope Medical Center
Exercise Intervention in Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast Cancer	NCT03091842	Cancer Survivor Central Obesity Estrogen Recept... Postmenopausal Progesterone Re... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea...	Exercise Interv... Exercise Interv... Exercise Interv... Informational I... Laboratory Biom... Quality-of-Life... Questionnaire A...	18 Years -	University of Southern California
Ultrasound in Detecting Taxane-Induced Neuropathy in Patients With Breast Cancer	NCT03139435	Peripheral Neur... Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast...	Biopsy Questionnaire A... Ultrasound Tomo...	-	Wake Forest University Health Sciences
Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy	NCT02314156	BRCA1 Mutation ... BRCA2 Mutation ... Ductal Breast C... Lobular Breast ... Stage 0 Breast ... Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIB Breas...	Telapristone Ac... Placebo Telapristone Ac... Placebo Laboratory Biom... Questionnaire A...	18 Years -	Northwestern University
Cardiac Rehabilitation Program in Improving Cardiorespiratory Fitness in Stage 0-III Breast Cancer Survivors	NCT03039140	Cancer Survivor Stage 0 Breast ... Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea...	Educational Int... Exercise Interv... Quality-of-Life... Questionnaire A...	30 Years - 75 Years	Ohio State University Comprehensive Cancer Center

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: